Proteins with expanded polyQ repeats are associated with at least nine neurodegenerative disorders including ataxins 1 and 3, Kennedy's disease, and Huntington's disease 1,2 . These diseases are dominantly inherited and although the polyQ-containing proteins are expressed widely in the brain, they result in selective neuronal death. There is a significant and striking correlation between the length of the polyQ repeat and pathology; longer repeats result in earlier onset and more severe symptoms with the threshold of approximately 40 glutamine residues. In the case of Huntington's disease, for example, expanded polyQ in huntingtin (Htt) protein causes disease 3, 4 . A characteristic of the polyQ diseases is the appearance of neuronal inclusions that are formed by aggregation of the polyQ proteins with other cellular proteins 5, 6 . This has led to the 'toxic gain-of-function' hypothesis that proposes that essential proteins can be sequestered, which over time leads to cellular dysgenesis. The expression of polyQ can cause other metastable proteins to lose functionality, and in turn these proteins amplify the toxicity of polyQ by enhancing overall aggregation 7 . Selfaggregation of polyQ proteins has been proposed to be mediated by association of parallel β-sheet structures 8 . However, the intrinsic in vivo events leading to the aggregation of polyQ proteins remain poorly understood.
Proteins with expanded polyQ repeats are associated with at least nine neurodegenerative disorders including ataxins 1 and 3, Kennedy's disease, and Huntington's disease 1, 2 . These diseases are dominantly inherited and although the polyQ-containing proteins are expressed widely in the brain, they result in selective neuronal death. There is a significant and striking correlation between the length of the polyQ repeat and pathology; longer repeats result in earlier onset and more severe symptoms with the threshold of approximately 40 glutamine residues. In the case of Huntington's disease, for example, expanded polyQ in huntingtin (Htt) protein causes disease 3, 4 . A characteristic of the polyQ diseases is the appearance of neuronal inclusions that are formed by aggregation of the polyQ proteins with other cellular proteins 5, 6 . This has led to the 'toxic gain-of-function' hypothesis that proposes that essential proteins can be sequestered, which over time leads to cellular dysgenesis. The expression of polyQ can cause other metastable proteins to lose functionality, and in turn these proteins amplify the toxicity of polyQ by enhancing overall aggregation 7 . Selfaggregation of polyQ proteins has been proposed to be mediated by association of parallel β-sheet structures 8 . However, the intrinsic in vivo events leading to the aggregation of polyQ proteins remain poorly understood.
Protein misfolding is a natural consequence of protein biogenesis. To combat cytotoxicity resulting from the accumulation of misfolded proteins, all cells express molecular chaperones that are essential for the productive folding of proteins 9, 10 . Molecular chaperones are of several classes; for example, Hsp70/J-domain proteins interact with unfolded or partially folded proteins in concert with co-chaperones, whereas the chaperone machines of the chaperonin (Hsp60) family form cage-like structures that sequester non-native states of proteins 11 . CCT is a member of the chaperonin family 12 that facilitates the folding of proteins in the eukaryotic cytosol on ATP hydrolysis 13, 14 . CCT shows a weak but significant homology to Eschericia coli GroEL and forms a hexadecamer double-troidal complex composed of eight different subunits 15, 16 . Substrate proteins are captured in the cavity and released after folding is completed 17 . Approximately 10% of newly synthesized proteins have been proposed to be recognized by CCT.
In a recent genome-wide screen to identify modifier genes for polyQ aggregation in Caenorhabditis elegans, approximately 200 genes were found to be required for the prevention of polyQ aggregation 18 . These included the genes encoding two Hsp70s, one J-protein and six CCT subunits. These observations suggested a role for CCT in preventing polyQ aggregation. Here, we show that CCT has a key protective role against the toxicity of Htt-polyQ in mammalian cells and affects the aggregation process at the soluble stage. In the context of our recent in vitro data showing that CCT prevents aggregation of the trimeric G protein β subunit (Gβ) by recognizing hydrophobic β-strands 19 , we discuss possible mechanisms for the CCT-dependent prevention of polyQ aggregation.
To address whether CCT has a direct role in polyQ aggregation and toxicity, the levels of CCT in human tissue culture cells were depleted using an RNA interference (RNAi)-mediated CCT subunit knockdown system. HEK293 cells were transiently transfected with a CCTζ small interfering RNA (siRNA) expression vector or a non-specific siRNA vector as a control, and the levels of CCT subunits were examined by western blot analysis (Fig. 1a and see Supplementary Information, Fig. S5 ). The level of CCTζ was reduced by more than 75%, indicating efficient knockdown of the subunit. Except for a slight reduction of the levels of CCTα and CCTε subunits, no significant effect of CCTζ knockdown was observed on the levels of the other subunits, indicating reasonably selective knockdown of the ζ subunit. Reduction in the levels of the ζ subunit did not affect overall cell morphology or cell-growth rates of transfected cells under the conditions described (data not shown). However, depletion of the ζ subunit did significantly reduce the levels of the CCT complex detected by sucrose density gradient analysis. In CCTζ-depleted cells, the majority (82%) of the CCT subunits were monomers or small oligomers, whereas in untreated cells essentially only the high molecular weight CCT complexes (96,000) were detected ( To examine whether reduction of CCT affected polyQ aggregation and toxicity phenotypes, we expressed different lengths of polyQ repeats fused with YFP (YFP, Q19-YFP and Q82-YFP) in HEK293 cells with the CCTζ siRNA vector or nonspecific siRNA vector. Following transfection, the fraction of aggregate-containing cells was monitored by fluorescent microscopy. A low level (10.9%) of the Q82-YFP transfected cells exhibited aggregates similar to previous observations 20 . On CCTζ depletion, there was a 2.5-fold increase in aggregate containing cells (Fig. 1c) . In contrast, no effect of CCTζ depletion was observed in cells expressing either Q19-YFP or YFP alone. It was also confirmed that the nonspecific RNAi vector exhibits no significant difference to a scrambled CCTζ RNAi control vector for the levels of CCTζ protein and polyQ aggregation (see Supplementary Information, Fig. S1c, d ). In addition, we examined whether depletion of other CCT subunits affected polyQ aggregation by RNAi knockdown and found that depletion of CCTα significantly stimulates Q82-GFP aggregation (Fig. 1d) . These results indicate that the effect of knockdown of different subunits of CCT is an enhancement of polyQ aggregation. These observations are consistent with the fact that all eight subunits are essential to form functional chaperonin complex.
The morphological characteristics of Q82-YFP inclusions observed in CCTζ knockdown cells were indistinguishable from control Q82-YFP expressing cells in terms of the numbers of aggregate structures per cell, aggregate size or perinuclear localization (Fig. 1e) . Consistent with the observed increase in the number of cells with aggregates, celluloseacetate filter-trap assay of cell lysates indicated that the cells depleted of CCT have increased levels of Q82-YFP aggregates (1.7-fold), whereas cells expressing either Q19-YFP or YFP alone did not form aggregates, even after CCTζ knockdown (Fig. 1f) .
We next examined whether changes in the levels of CCT influenced Htt phenoytpes using HeLa cells stably expressing HttQ143-YFP or HttQ23-YFP under the control of Tet-off system. In HttQ143-YFP cells transfected with the CCTζ knockdown vector (transfected cells were identified by cotransfection with mRFP1 vector), the fraction of cells with aggregates increased 2.8-fold (Fig. 2a) . Aggregate size and morphology was unaltered (Fig. 2b ) similar to previous reports 20, 21 . Consistent with the observed increase in numbers of aggregate-containing cell numbers, a 7.5-fold increase in aggregated Htt protein levels was detected by the filter trap assay (Fig. 2c) . Aggregation of HttQ55 fused with a HA tag consisting of only ten amino acids was also stimulated by depletion of each of two different subunits tested (Fig. 2d and see Supplementary Information, Fig. S2c) , confirming that the stimulation of Htt aggregation by depletion of specific CCT subunits was not influenced by the heterologous presence of the YFP (GFP) tag. Thus, CCT is required to prevent the aggregation of polyQ-expansion proteins, including Htt.
It has been shown previously that Hsp70 inhibits polyQ aggregation in vitro and in vivo 22, 23 . Hsp70 colocalizes to Htt-polyQ aggregates and exhibits dynamic interactions in human cells unlike other associated cellular proteins that are stably sequestered 24 . We therefore examined the subcellular localization of CCT in Htt aggregate-containing cells by immunostaining and detected the diffuse distribution of CCT throughout the cytosol, but not in association with visible Htt inclusions (Fig. 2e) . Similar results were obtained for Q82-YFP inclusions (see Supplementary Information, Fig. S1e ). These results are consistent with the distinct chaperone activities between CCT and Hsp70. As CCT functions as a cage for folding reactions, we postulate that CCT is diffusely distributed in the cytosol in proximity of translating ribosomes. Consistent with this notion, colocalization of CCT with soluble HttQ143-YFP and ribosomes was observed in cells with no visible inclusion (Fig. 2f) . Thus, CCT may affect aggregation process of Htt at an earlier soluble stage.
To address how CCT influences polyQ aggregation states, we employed dynamic imaging methods. Fluorescence recovery after photobleaching (FRAP) analysis did not reveal any differences in the mobility of polyQ-GFP on depletion of CCT (see Supplementary Information, Fig. S3 ), therefore we turned to fluorescence correlation spectroscopy, a method developed for the analysis of rapid movement of fluorescent molecules at near single molecule levels 25, 26 . After cotransfection of HEK293 cells with polyQ-GFP and RNAi vectors for 72 h, cell extracts were prepared and the soluble fractions were analysed by fluorescence correlation spectroscopy. The record of fluorescent fluctuation indicated that significant numbers of slowly diffusing bright molecules were passing through the confocal volume in the soluble fraction prepared from cells expressing Q82-GFP or HttQ143-YFP under CCT depleted conditions (Fig. 3a) . The shift of correlation curves to larger diffusion times of Q82-GFP by CCTζ depletion indicates that molecular sizes of the polyQ protein have become significantly larger as the levels of CCT are reduced (Fig. 3b) . In contrast, Q19-GFP or GFP alone exhibited no significant difference in diffusion on CCT depletion. Curve fitting of these data (Table 1) indicates that a fraction of Q82-GFP (F2) diffuses much more slowly than monomer fractions (F1), even in the untreated cells. The diffusion constants of these fractions indicate that the slow fraction diffuses eightfold (or greater) more slowly than monomers and that the content of the slow fraction was increased by twofold (8.7% versus 4.6%) after CCTζ knockdown. Similarly, an increase in diffusion mobility in the soluble fraction of HttQ143-YFP expressing HeLa cells was observed, whereas HttQ23-YFP and YFP showed no difference (Fig. 3b) . The diffusion of the slow fraction of HttQ143-YFP was 30-fold slower than monomers and its relative content was increased significantly (1.2% to 6.5%) by CCT depletion (Table 1 ). In contrast, no difference of diffusion mobility was observed at earlier times of 24 or 48 h (see Supplementary  Information, Fig. S4 ). The slow fraction of Q82-YFP or HttQ143-YFP thus appeared within the last 24 h of the 72 h RNAi treatment, corresponding to the same period when visible aggregates formed (no aggregates were observed at 24 and 48 h treatment, data not shown). Soluble aggregates of Q82-GFP were also detected in CCT-depleted cells using sucrose gradient centrifugation followed by western blotting, whereas they were hardly detected in control cells probably due to the detection limit of the method (see Supplementary Information, Fig. S1f ). Taken together, these data support the hypothesis that inhibition of CCT function enhances the appearance of soluble Htt-polyQ aggregates leading to the formation of visible inclusions.
To examine whether changes in the level of CCT also affected HttpolyQ-induced neuronal cell death, Htt was expressed in Neuro2a cells where CCT subunits were depleted. Reduction of CCT subunits resulted in a near doubling of polyQ expansion-dependent cell death (Fig. 4a) , together with a twofold stimulation of aggregation (Fig. 4b) . We next asked whether overexpression of CCT subunits would suppress HttpolyQ aggregation and cytotoxicity. To achieve increased expression of the CCT complex, Neuro2a cells were cotransfected with expression vectors for all eight CCT subunits (Fig. 4e, f) . This resulted in a significant inhibition of HttQ78 aggregation in Neuro2a cells (Fig. 4d ) and polyQ82 aggregation in HEK293 cells (see Supplementary Information, Fig. S1g ). In contrast, overexpression of only a single subunit of CCT had no effect on polyQ82 aggregation (see Supplementary Information, Fig. S1h ). Simultaneous overexpression of all eight CCT subunits reduced cell death of the Neuro2a expressing HttQ78 by more than 50% (Fig. 4c) , thus indicating that CCT has a positive protective role against the cytotoxicity of polyQ-expansion proteins like Htt.
Here, we have shown that changes in the levels of the cytosolic chaperonin CCT affect the aggregation state and toxicity of Htt-polyQ proteins in mammalian cells. RNAi knockdown of CCT subunits disrupt the CCT complex and consequently blocks its ability to trap substrates 16, 17 . Intriguingly, our fluorescence correlation spectroscopy experiments revealed that depletion of CCT subunits results in the appearance of soluble polymeric Htt-polyQ species, whereas CCT knockdown does not alter size or morphology of finally formed visible aggregates. Thus, CCT seems to inhibit aggregate formation at an earlier soluble stage.
Using an in vitro translation system reconstituted with purified proteins, we recently demonstrated that CCT prevents aggregation of newly synthesized Gβ 19 , a WD40 repeat protein very rich in β-sheets. Detailed analysis of the CCT binding regions in Gβ revealed that CCT specifically recognize hydrophobic β-strands. Thus, a specific function of CCT may be to protect against aggregation of hydrophobic β-sheets. Consistent with this proposal, CCT has been shown to bind hydrophobic β-strands in VHL 27 and interact with the WD40 family β-sheet rich proteins in vivo 28 . As polyQ repeats are known to form β-sheet structures in aggregates, CCT may be essential for trapping β-sheet structures required for aggregate formation. HSP70 has been shown to prevent Htt-polyQ aggregation in vitro 22 and transiently interacts with visible aggregates in vivo 24 . In contrast, we show here that CCT subunits do not concentrate in the visible Htt-polyQ aggregate structure but rather remain localized throughout the cytosol. As CCT functions as a cage-like machine that assists in folding of substrates by trapping them within the cavity, the structure of CCT may prevent association with large insoluble inclusions. Our data from fluorescence correlation spectroscopy analysis supports this hypothesis because CCT affects the formation of soluble aggregates but not of the large visible aggregates. Although we do not know the exact mechanism by which CCT affects polyQ folding, these observations suggest a biochemical process that is distinct from the mechanisms proposed for Hsp70 interaction with unfolded and partially folded substrates. Differences in the levels of the Hsp70 and CCT chaperones could therefore influence aspects of cell type sensitivity to the stress of misfolded proteins.
Overexpression of the CCT complex has a significant inhibitory effect on the aggregation and cytotoxicity of Htt-polyQ in mammalian cells. Therefore, modulation of CCT function may offer an approach to prevent neurodegenerative disorders caused by protein aggregation including polyQ diseases. 
METHODS

Constructs.
Plasmid vectors expressing siRNAs for 21-nucleotide target sequences of human CCTζ-1 mRNA (AAGTCTGTGGCGATTCAGATA), human CCTα mRNA (AAATACTAAGGCTCGTACGTC) and mouse CCTζ-1 mRNA (AAGTCTGTGGTGACTCAGATA) were constructed using pSUPER (OligoEngine, Seattle, WA). A non-silencing control vector expressing nonspecific siRNA (NS-pSUPER) was obtained from Dharmacon, Lafayette, CO. Expression vectors for polyQ-EYFP and polyQ-EGFP were described previously 20, 24 . Expression vectors for Htt-exon-1 fused with EYFP were produced as previously described 21 and the Htt-exon-1 gene inserts were then subcloned into pEGFP-N1 (Invitrogen, Carlsbad, CA) for Htt-EGFP expression vectors. mRFP1 expression vector was constructed by excising the mRFP1 insert from mRFP1-pRsetB 29 and subcloned into pEGFP-C1 vector after removing the EGFP segment. For overexpression of eight CCT subunits, human cDNAs of individual subunits were separately cloned into pCAGGS expression vector.
Cell culture, transfection and biochemical analysis. HEK293, HeLa and Neuro2a cells were cultured in DMEM supplemented with 10% foetal bovine serum. HeLa stable cell lines carrying Tet-off-regulated Htt-EYFP genes were cloned and maintained as previously described 21 . HEK293, HeLa and Neuro2a cells were transfeceted using Lipofectamine 2000, Optifect (Invitrogen) and Effectene (Qiagen, Dusseldorf, Germany), respectively. For the HeLa stable cell lines, they were cotransfected with mRFP1 and other plasmids, and cells emitting red colour signals for mRFP1 were considered transfected cells. Determination of protein concentration, western blotting analysis and sucrose gradient fractionation were performed as previously described 30 . For CCT subunit overexpression experiments, Neuro2a cells (3.5-cm dish) were transfected with the eight CCT subunit expression vectors (10 ng each), Htt-GFP (100 ng) and empty pCAGGS (320 ng). For control experiments, the CCT subunit expression vectors were replaced by the same amount of empty pCAGGS.
Analysis of aggregate-containing cells. Cells were grown on coverslips coated with poly-l-lysine for HEK293 cells, type I collagen for HeLa cellsor type IV collagen for Neuro2A cells, respectively. At 72 h after transfection, cells were fixed with 4% paraformaldehyde in PBS for 15 min and stained with Hoechst 33342. Images were taken by an Axioplan2 microscope with Plan-NeoFluar 40× 0.75 NA objective (Carl Zeiss, Jena, Germany).
Analysis of cell death. Neuro2a cells were grown on φ27 glass-bottom dish coated with type IV collagen for 16 h. Immediately after transfection of Htt-GFP expression vectors, neuronal cell differentiation was induced by addition of 5 mM dibutyryl cAMP for 72 h. Cells stained with propidium iodide (1 µg ml -1 ) were counted as dead cells using a Biozero digital microscope (Keyence, Osaka, Japan) through a PlanFluor 10× 0.30 NA objective (Nikon, Tokyo, Japan).
Filter-trap assay. Cells were lysed in PBS containing 0.5% Triton X-100 and protein concentrations were determined. Lysates were diluted in 1% SDS-PBS and boiled for 5 min. Immediately after cooling, samples were loaded onto cellulose acetate membrane (0.2 µm) settled on a dot blotter (Bio-Rad, Hercules, CA). After blocking with 1% skim milk and 0.05% Tween 20 in PBS overnight, the membrane was incubated with mouse anti-GFP antibody (GA200, Nacalai Tesque, Kyoto, Japan) and alkaline-phosphatase conjugated anti-mouse IgG antibody (Biosource, Camarillo, CA). Alkaline-phosphatase activity was detected by developing in NBT-BCIP (nitro-blue tetrazolium chloride and 5-bromo-4-chloro-3´-indolylphosphatase p-toluidine salt) solution (Sigma-Aldrich, St Louis, MO).
Immunofluorescence microscopy. Cells grown on coverslips were fixed in methanol at -20 °C for 5 min or 4% paraformaldehyde in PBS at 37 °C for 15 min and washed three times in PBS. After treatment with 0.5% Triton X-100 and 0.5% saponin in PBS for 5 min, cells were blocked with 1% BSA, 10% glycerol and 0.02% Triton X-100 in PBS. Cells were incubated with rabbit anti-CCTγ antibody (1:50), rat anti-HSC70 antibody (1:100, SPA-815, Stressgen, Ann Arbor, MI), mouse anti-α-tubulin antibody (1:200, DM1A, CalbioChem, San Diego, CA), mouse anti-GFP antibody (1:100), or goat anti-ribosomal protein L11 (1:50, sc-25931, SantaCruz, Santa Cruz, CA) and then with AlexaFluor 488 or 594 conjugated anti-rabbit, rat, goat, or mouse IgG (1:200, Molecular Probes, Carlsbad, CA). At the second antibody incubation, cells were costained with 1.0 µg ml -1 Hoechst 33342 for nuclear staining. Images were collected by LSM 510 META confocal microscope through a Plan-Apochromat 63× 1.4 NA oil-immersion objective (Carl Zeiss). The pinhole aperture for Hoechst, YFP and Alexa594 channels were settled at 84 µm, 94 µm and 127 µm, respectively.
Fluorescence correlation spectroscopy analysis. Fluorescence correlation spectroscopy measurements were performed by a ConfoCor 2 system with C-Apochromat 40× 1.2NA water immersion objective lens (Carl Zeiss). EGFP and EYFP were excited at 488 nm and 514 nm, respectively. Confocal pinhole diametres were adjusted to 70 µm at 488 nm, or 74 µm at 514 nm. Emission signals were detected by a 505 nm long-pass filter for EGFP or a 530-600 nm band-pass filter for EYFP. Cells (3.5-cm dish) were lysed in 0.2 ml PBS by passing through a 27 gauge needle and the supernatant was recovered after centrifugation (10,000g, 2 min) and diluted appropriately. Fluorescence signals of the supernatant were recorded on Lab-Tek 8-well chamber slides at 25 °C. The fluorescence autocorrelation functions, G(τ), from which the average residence time (τ i ) and the absolute number of fluorescent proteins in the detection volume are calculated, are obtained as follows:
where I (t + τ) is the fluorescence intensity obtained by the single photon counting method in a detection volume at a delay time τ (brackets denote ensemble averages). The curve fitting for the multi-component model is given by: where y i and τ i are the fraction and the diffusion time of the component i, respectively; N is the average number of fluorescent molecules in the detection volume defined by the beam waist w 0 and the axial radius z 0 ; and s is the structure parameter representing the ratio of w 0 and z 0 . All G(τ)s in aqueous solutions were measured ten times for 20 s. After pinhole adjustment, diffusion time and structure parameter were determined using a 10 -7 M rhodamine 6G (Rh6G) solution as a standard before measurements. The values of structural parameters were 6.1-6.6 for GFP and 5.5-6.6 for YFP, respectively. The diffusion constants of fluorescent molecules (D sample ) were calculated from the published diffusion constant of Rh6G, D Rh6G (280 µm 2 s -1
) and measured diffusion times of Rh6G at the condition (τ Rh6G ) and probe proteins (τ sample ) as follows: 
